Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762760 · ClinicalTrials.gov registry record · Phase 1
AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint
A Phase 1 study of Osteoarthritis of the Hand, sponsored by Ampio Pharmaceuticals..
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02762760 is a Phase 1 study of Osteoarthritis of the Hand that has completed, run by Ampio Pharmaceuticals.. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02762760, a Phase 1 study of Osteoarthritis of the Hand, has completed, sponsored by Ampio Pharmaceuticals..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the basal thumb joint.
Conditions Studied
Interventions
- BIOLOGICAL Saline
- BIOLOGICAL AMPION™
Study Locations (1)
Colorado
- Ampio Pharmaceuticals - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02762760
The ClinicalTrials.gov registry entry for NCT02762760 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ampio Pharmaceuticals., which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis of the Hand appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT02762760 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT02762760 about?
NCT02762760 is a clinical study titled "AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint". This study will evaluate the safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the basal thumb joint.
What is the current status of trial NCT02762760?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2016-05. Estimated completion is 2016-11.
What conditions does trial NCT02762760 study?
This clinical trial studies the following conditions: Osteoarthritis of the Hand.
What interventions are being tested in trial NCT02762760?
The interventions under investigation include: Saline (BIOLOGICAL), AMPION™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT02762760?
This trial is sponsored by Ampio Pharmaceuticals., which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02762760 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.